| 名稱 | TEL(ETV6)-JAK2/BaF3 | 
| 型號(hào) | CBP73117 | 
| 報(bào)價(jià) | ![]()  | 
								
| 特點(diǎn) | TEL(ETV6)-JAK2/BaF3,母細(xì)胞:BaF3,凍存條件:90% FBS+10% DMSO; | 
產(chǎn)品搜索
相關(guān)文章
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
					產(chǎn)品展示  / PRODUCTS
					
						藥靶細(xì)胞株 > kinase激酶細(xì)胞株  >  CBP73117TEL(ETV6)-JAK2/BaF3
            
              
					
				
				
						- 詳細(xì)內(nèi)容
 
| CBP73117 | |
| I. Introduction | |
Cell Line Name:  | TEL(ETV6)-JAK2/BaF3  | 
Host Cell:  | Ba/F3  | 
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) | 
Application:  | This kit is useful for screening for small molecules displacing ATP from the JH2 domain of JAK2.  | 
Freeze Medium:  | 90% FBS+10% DMSO  | 
Complete Culture Medium:  | RPMI-1640+10%FBS+2ug/ml puromycin  | 
Mycoplasma Status:  | Negative  | 
| II.Background | |
JAK2, Janus kinase 2, is a non-receptor protein tyrosine kinase that binds cytokine receptors to activate the interferon-alpha/beta/gamma pathway and is a member of the JAK/STAT signaling pathway (PMID: 15575979, PMID: 30092288). JAK2 mutations are observed in a variety of tumor types, including myeloproliferative neoplasms (PMID: 30074114), lymphoma (PMID: 29984752), leukemia (PMID: 29979407), and cervical cancer (PMID: 30003068).  | |
| III. Representative Data | |
1.WB of BA/F3/TEL(ETV6)-JAK2 
  | |
2. Anti-proliferation assay  | |
 
 Figure 2. CTG Proliferation Assay of BaF3 TEL-JAK2 (C1).  | |






會(huì)員_a.png)